• USFDA has given green signal for the production of Fingomolid Capsules that are used in treatment of relapsed form of multiple sclerosis in adults
• At present, Glenmark's portfolio comprises of 164 products authorized for distribution in the US market
• Shares of Glenmark Pharma saw intraday high of Rs 411.20 on the BSE
Glenmark Pharmaceuticals, world’s leading phar....
Tags : Glenmark Pharmaceuticals, Fingomolid Capsules, Gilenya Capsules, USFDA,